Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OptiOFS: Alternative Site Goserelin Acetate Injection for OFS in Breast Cancer
NCT07460752Phase 2Recruiting
- Sponsor
- Mayo Clinic
- Start
- May 2026
- Primary completion
- Dec 2028
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of goserelin in breast cancer, sponsored by Mayo Clinic. Started May 2026; status: recruiting.
02
Drugs
goserelin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07460752.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07460752.